&w=3840&q=100)
Mastek shares gain 6% on strategic deal with Zulekha Healthcare; details
Mastek share price today: Shares of digital engineering and cloud transformation services provider Mastek were buzzing in trade on Thursday, May 8, 2025. The company's share price soared 6.14 per cent to ₹2,223 during intra-day trade on Thursday.
The upward movement in the company's share price came following its announcement of a strategic collaboration with Zulekha Healthcare Group, a UAE-based healthcare services provider.
Mastek, in a release, said that it will deploy an extensive Oracle Fusion Cloud suite, which closely integrates with the Oracle Health (Cerner) system.
"This transformation aligns with Zulekha's vision of delivering 'Patient First' healthcare while enhancing clinical workflows, operational efficiency, and fiscal agility," Mastek said in the release. "As a leading Oracle Cloud partner with 1,500+ implementations across 40+ countries, 100+ industry-specific solutions, and a talent pool of 2,000+ skilled consultants, Mastek will implement a unified Oracle Fusion Cloud solution fully integrated with Zulekha Healthcare Group's Hospital Information System (HIS) and Revenue Cycle Management (RCM)."
'Leveraging Mastek's close working relationship with Oracle and deep healthcare domain expertise, we empower organisations like Zulekha Healthcare Group to achieve smarter, faster, and more patient-centric operations. We are committed to supporting their transformation journey and are excited to drive innovation and deliver measurable outcomes together,' said Surya Nunna, Executive Vice President, AMEA, Mastek.
About Mastek
Mastek is a global provider of enterprise AI, digital, and cloud services, enabling its clients to achieve measurable and sustainable returns on their technology investments. The company partners with industry leaders such as Oracle, Salesforce, Microsoft, AWS, Snowflake, and Databricks, serving key sectors such as Public Sector, Healthcare, Retail, Manufacturing, Higher Education, and Financial Services. Mastek is a solutions-focused and relationship-centric company that values both employees and clients.
As of May 8, the company boasts a market capitalisation of ₹6,770.89 crore on the NSE.
Mastek share price history
The shares of the Computers - Software & Consulting company have exhibited a mixed performance over the past year. Mastek's share price has advanced nearly 11 per cent in the last month, while it has declined 25 per cent in the last six months and 13 per cent in the last year.
For the year-to-date, Mastek's share price has posted a decline of nearly 27 percent. In contrast, the benchmark Nifty50 has advanced nearly 2.5 per cent this year.
At around 1:50 PM on Thursday, Mastek's shares were quoted at approximately ₹2,171.90, up 3.70 per cent from its previous close of ₹2,094.40 on the NSE.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
2 hours ago
- The Hindu
TTD initiates trial of anti-drone surveillance system at Tirumala
In a proactive move to strengthen security around Lord Venkateswara temple, the Tirumala Tirupati Devasthanams (TTD) has initiated the trial of a cutting-edge anti-drone surveillance system. The aim is to enhance aerial security and prevent unauthorised drone activity in the airspace of the temple town. The move comes in light of heightened national security concerns and recent war-like scenarios at the country's frontiers. TTD Chairman B.R. Naidu, Executive Officer J. Shyamala Rao and Additional EO Ch. Venkaiah Chowdary recently took part in a demonstration carried out by a Hyderabad-based drone manufacturing company. They urged the police and vigilance officials to examine the proposed anti-drone system and submit a report within ten days. The company is learnt to have been manufacturing anti-drone systems with Israeli technology. In light of the anti-drone system recently installed by the Central government at the Golden Temple in Amritsar, the TTD officials are preparing plans to implement similar security measures in Tirumala and seek the support of the Defence Research and Development Organization (DRDO) in this regard.
Time of India
2 hours ago
- Time of India
File FIR against power station related to land mortgage in Kabini: MLA
Mysuru: HD Kote MLA Anil Chikkamadu instructed officials to file an FIR against Kabini Subhash Power Station in connection with allegations of obtaining loans by mortgaging govt land in Kabini. The issue was discussed in a Karnataka Development Programmes review meeting held in HD Kote, concerning accusations that the Kolkata-based Subhash Power Station Corporation Limited attempted to illegally acquire govt land within the Kabini reservoir. Following complaints of public outcry about the misuse of govt land from the public and people from various quarters of society, the MLA directed Saragur tahsildar Mohankumari and officials concerned with Cauvery Neeravari Nigam Limited to look into such complaints. Even though state govt permitted the company to set up the power corporation after providing it land on a 30-year lease, the company is accused of transferring 13 acres into its name. It also obtained necessary khatas, RTCs, and fraudulently borrowed loans from several nationalised and private sector banks. Speaking to TOI, social activist Doreswamy, a retired police officer, accused the previous tahsildar and other revenue department officers of Saragur taluk of allegedly transferring 13 acres belonging to the state irrigation department to this company. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Click Here - This Might Save You From Losing Money Expertinspector Click Here Undo They also issued khata, RTC, and other land records. He demanded state govt and irrigation department order a detailed probe into these allegations. Previous Saragur revenue department officials, including the tahsildar, transferred 13 acres of govt land bearing registration numbers 160, 161, and 162 to this company. Doreswamy said he would continue the legal battle over the issue. Executive engineer of Kabini reservoir, Beechanahalli, Chandarashekhar, said he would verify this complaint and initiate action after discussing the issue with his higher-ups. Senior manager of Subhash Power Station Corporation Limited V Senthilkumar denied such allegations levelled against the company and said they are ready for investigation as they did not commit any wrongdoing. They haven't obtained any loans after mortgaging property belonging to the state irrigation department. The company has also written letters to the state revenue department, local tahsildar, and even irrigation department officials of Kabini reservoir to rectify the error if the company's name is mentioned in RTCs and other land records.
Time of India
3 hours ago
- Time of India
AU experts develop compounds that may boost human memory
Prayagraj: In a breakthrough development, scientists from Allahabad University (AU) have identified 14 chemical compounds that could significantly enhance human memory. These compounds, developed in the university's chemistry laboratory, show promising effects in opening constricted brain neurons, which are often associated with memory loss and cognitive decline. Tired of too many ads? go ad free now The research, led by Prof Ramendra Kumar Singh of the Department of Chemistry at AU, marks a major advancement in the search for memory-enhancing drugs. Remarkably, the compounds developed in the Prayagraj-based university are currently undergoing international testing in laboratories in the United States, specifically at California State University, Fullerton. According to Prof Singh, preliminary results from the testing of three compounds showed positive outcomes, suggesting their potential in combating memory-related disorders. A research paper detailing this discovery was recently published in the Netherlands-based scientific journal, Journal of Molecular Structure, further highlighting the global relevance of this work. Explaining the scientific basis of the study, Prof Singh said that hyperphosphorylated tau proteins—proteins with an excess of phosphate groups—are responsible for memory degradation in humans. These proteins accumulate in the brain due to a deficiency of a neurotransmitter called acetylcholine. The enzyme acetylcholinesterase is responsible for breaking down acetylcholine, thus leading to its depletion. The 14 newly developed compounds aim to inhibit the function of acetylcholinesterase, thereby maintaining healthy acetylcholine levels and potentially improving memory and brain health. To identify these compounds, the research team conducted a series of chemical reactions in the lab and utilised computational techniques such as molecular docking and computer simulation to evaluate the compounds' activity and cytotoxicity. Tired of too many ads? go ad free now The detailed analysis confirmed that all 14 compounds showed significant promise in both effectiveness and safety. These compounds, after being encoded, were sent to California for second-phase testing on specific cell lines known to produce the tau protein responsible for Alzheimer's disease. Although the names of the compounds have not yet been disclosed, Prof Singh noted that the early-stage results are encouraging, with three compounds already delivering positive findings. The next steps in the research include developing a drug based on the most effective molecule. If successful, this could lead to a new therapeutic option for millions suffering from memory loss and neurodegenerative conditions like Alzheimer's.
